Intellia to Kick-start First Single-course 'Curative' CRISPR Shot, as it Hopes to Beat Rivals Alnylam, Ionis, and Pfizer

https://www.fiercebiotech.com/biotech/intellia-to-kickstart-first-single-course-curative-crispr-shot-as-it-hopes-to-beat-rivals
JOIN OUR MAILING LIST